BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Truvian Sciences Inc.

Headquarters: San Diego, CA, United States
Year Founded: 2015
Status: Private

BioCentury | Jul 18, 2024
Finance

Venture Report: Five biotechs raise nearly $800M in two-day flurry 

Plus: New capital for CytoReason, Truvian and Renalys
BioCentury | Oct 5, 2022
Management Tracks

Owkin finds new CBO in Sanofi SVP

Plus CEO Séjourné moves to Aurobac and updates from Quantum, BioHaven and more
BioCentury | Feb 25, 2021
Deals

Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen, AmacaThera, and more

ICON plc (NASDAQ:ICLR) is buying fellow CRO PRA Health Sciences Inc. (NASDAQ:PRAH) in a cash and stock transaction valued at about $12 billion. The deal combines ICON’s Accellacare site
Items per page:
1 - 4 of 4
Help Center
Username
Request Training
Submit Data Correction
Ask a Question